vs

Side-by-side financial comparison of Emerson Electric (EMR) and State Street Corporation (STT). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.7B, roughly 1.2× State Street Corporation). State Street Corporation runs the higher net margin — 20.4% vs 13.9%, a 6.5% gap on every dollar of revenue. On growth, State Street Corporation posted the faster year-over-year revenue change (7.5% vs 4.1%). State Street Corporation produced more free cash flow last quarter ($9.8B vs $602.0M). Over the past eight quarters, State Street Corporation's revenue compounded faster (8.1% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

State Street Corporation is an American multinational financial services and bank holding company headquartered at One Congress Street in Boston. It is the second-oldest continuously operating U.S. bank, tracing its roots to Union Bank, chartered in 1792. As of the third quarter of 2025, State Street is one of the world's largest asset managers and custodians, with approximately US$5.4 trillion in assets under management and US$51.7 trillion under custody and administration.

EMR vs STT — Head-to-Head

Bigger by revenue
EMR
EMR
1.2× larger
EMR
$4.3B
$3.7B
STT
Growing faster (revenue YoY)
STT
STT
+3.4% gap
STT
7.5%
4.1%
EMR
Higher net margin
STT
STT
6.5% more per $
STT
20.4%
13.9%
EMR
More free cash flow
STT
STT
$9.2B more FCF
STT
$9.8B
$602.0M
EMR
Faster 2-yr revenue CAGR
STT
STT
Annualised
STT
8.1%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EMR
EMR
STT
STT
Revenue
$4.3B
$3.7B
Net Profit
$605.0M
$747.0M
Gross Margin
53.2%
Operating Margin
17.8%
25.0%
Net Margin
13.9%
20.4%
Revenue YoY
4.1%
7.5%
Net Profit YoY
3.4%
-4.6%
EPS (diluted)
$1.07
$2.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
STT
STT
Q4 25
$4.3B
$3.7B
Q3 25
$4.9B
$3.5B
Q2 25
$4.6B
$3.4B
Q1 25
$4.4B
$3.3B
Q4 24
$4.2B
$3.4B
Q3 24
$4.6B
$3.3B
Q2 24
$4.4B
$3.2B
Q1 24
$4.4B
$3.1B
Net Profit
EMR
EMR
STT
STT
Q4 25
$605.0M
$747.0M
Q3 25
$637.0M
$861.0M
Q2 25
$586.0M
$693.0M
Q1 25
$485.0M
$644.0M
Q4 24
$585.0M
$783.0M
Q3 24
$996.0M
$730.0M
Q2 24
$329.0M
$711.0M
Q1 24
$501.0M
$463.0M
Gross Margin
EMR
EMR
STT
STT
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
52.8%
Q1 24
52.2%
Operating Margin
EMR
EMR
STT
STT
Q4 25
17.8%
25.0%
Q3 25
16.4%
31.1%
Q2 25
16.1%
25.8%
Q1 25
14.2%
25.0%
Q4 24
18.6%
28.1%
Q3 24
14.7%
28.4%
Q2 24
10.4%
28.6%
Q1 24
16.2%
19.1%
Net Margin
EMR
EMR
STT
STT
Q4 25
13.9%
20.4%
Q3 25
13.1%
24.3%
Q2 25
12.9%
20.1%
Q1 25
10.9%
19.6%
Q4 24
14.0%
22.9%
Q3 24
21.6%
22.4%
Q2 24
7.5%
22.3%
Q1 24
11.4%
14.8%
EPS (diluted)
EMR
EMR
STT
STT
Q4 25
$1.07
$2.41
Q3 25
$1.12
$2.78
Q2 25
$1.04
$2.17
Q1 25
$0.86
$2.04
Q4 24
$1.02
$2.43
Q3 24
$1.74
$2.26
Q2 24
$0.57
$2.15
Q1 24
$0.87
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
STT
STT
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$20.3B
$27.8B
Total Assets
$41.9B
$366.0B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Total Debt
EMR
EMR
STT
STT
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
EMR
EMR
STT
STT
Q4 25
$20.3B
$27.8B
Q3 25
$20.3B
$27.6B
Q2 25
$19.9B
$27.3B
Q1 25
$19.2B
$26.7B
Q4 24
$20.5B
$25.3B
Q3 24
$21.6B
$25.8B
Q2 24
$20.8B
$24.8B
Q1 24
$20.9B
$24.4B
Total Assets
EMR
EMR
STT
STT
Q4 25
$41.9B
$366.0B
Q3 25
$42.0B
$371.1B
Q2 25
$42.5B
$376.7B
Q1 25
$42.0B
$372.7B
Q4 24
$42.6B
$353.2B
Q3 24
$44.2B
$338.5B
Q2 24
$45.6B
$325.6B
Q1 24
$46.4B
$338.0B
Debt / Equity
EMR
EMR
STT
STT
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
STT
STT
Operating Cash FlowLast quarter
$699.0M
$10.0B
Free Cash FlowOCF − Capex
$602.0M
$9.8B
FCF MarginFCF / Revenue
13.9%
266.6%
Capex IntensityCapex / Revenue
2.2%
7.3%
Cash ConversionOCF / Net Profit
1.16×
13.44×
TTM Free Cash FlowTrailing 4 quarters
$4.4B
$10.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
STT
STT
Q4 25
$699.0M
$10.0B
Q3 25
$3.1B
$7.9B
Q2 25
$1.1B
$-8.4B
Q1 25
$241.0M
$2.4B
Q4 24
$777.0M
$-7.4B
Q3 24
$3.3B
$2.7B
Q2 24
$1.1B
$-7.6B
Q1 24
$743.0M
$-844.0M
Free Cash Flow
EMR
EMR
STT
STT
Q4 25
$602.0M
$9.8B
Q3 25
$2.7B
$7.7B
Q2 25
$977.0M
$-8.8B
Q1 25
$154.0M
$2.2B
Q4 24
$694.0M
$-7.7B
Q3 24
$2.9B
$2.5B
Q2 24
$998.0M
$-7.9B
Q1 24
$661.0M
$-1.1B
FCF Margin
EMR
EMR
STT
STT
Q4 25
13.9%
266.6%
Q3 25
54.9%
216.0%
Q2 25
21.5%
-254.1%
Q1 25
3.5%
66.1%
Q4 24
16.6%
-225.1%
Q3 24
63.1%
75.9%
Q2 24
22.8%
-246.2%
Q1 24
15.1%
-34.2%
Capex Intensity
EMR
EMR
STT
STT
Q4 25
2.2%
7.3%
Q3 25
8.9%
6.9%
Q2 25
2.0%
9.3%
Q1 25
2.0%
6.9%
Q4 24
2.0%
7.3%
Q3 24
9.1%
7.2%
Q2 24
2.1%
6.7%
Q1 24
1.9%
7.3%
Cash Conversion
EMR
EMR
STT
STT
Q4 25
1.16×
13.44×
Q3 25
4.86×
9.18×
Q2 25
1.83×
-12.18×
Q1 25
0.50×
3.72×
Q4 24
1.33×
-9.49×
Q3 24
3.35×
3.71×
Q2 24
3.31×
-10.75×
Q1 24
1.48×
-1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

STT
STT

Other$2.2B59%
Investment Management$729.0M20%
Management Services$662.0M18%
Other Fee Revenue$56.0M2%
Securities Financing Services$54.0M1%

Related Comparisons